当前位置: X-MOL 学术Lancet Haematol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Maintaining the minimal: dynamics of measurable residual disease with continuous lenalidomide therapy.
The Lancet Haematology ( IF 24.7 ) Pub Date : 2021-06-01 , DOI: 10.1016/s2352-3026(21)00140-x
Susan Bal 1 , Luciano J Costa 1
Affiliation  



中文翻译:

维持最小:持续来那度胺治疗可测量残留病灶的动态。

更新日期:2021-06-01
down
wechat
bug